Navigation Links
WuXi Manufacturing Facility Passes FDA Inspection
Date:10/29/2013

SHANGHAI, Oct. 29, 2013 /PRNewswire/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that the small molecule API and advanced intermediate manufacturing facility of WuXi's wholly owned subsidiary Shanghai SynTheAll Pharmaceutical Co. Ltd. (STA) completed a general GMP and Pre-Approval Inspection from the U.S. Food and Drug Administration with no Form 483 issued.

STA has built a substantial manufacturing pipeline of small molecule APIs and advanced intermediates for our global clients through its integrated platform, which extends from process research and research manufacturing to commercial manufacturing.  This inspection outcome confirms STA's capabilities in helping the clients move their new chemical entities through clinical development stages and eventually to commercial launch in the global market.  

"The result of this inspection speaks to WuXi's high standards of quality," said Dr. Ge Li, Chairman and CEO of WuXi PharmaTech.  "We continue to leverage our knowledge and that of our partners to build and operate a first-class quality system in China that meets global regulatory requirements."

About WuXi PharmaTech

As a research-driven and customer-focused company, WuXi PharmaTech (Cayman) Inc. provides a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process.  WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D.  WuXi AppTec is the name for the operating subsidiaries of WuXi PharmaTech.  Please visit http://www.wuxiapptec.com.

For more information, please contact:

Ronald Aldridge
Director of Investor Relations
+1-201-585-2048
ron_aldridge@wuxiapptec.com  

Aaron Shi
Associate Director of Corporate Communications
+86-21-5046-4362
pr@wuxiapptec.com  


'/>"/>
SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
2. Althea Technologies Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing And Jack Wright, VP, Sales and Marketing
3. Next Generation Pharmaceutical Manufacturing Summit Pushes the Envelope of Thought-Leadership at its September Summit in London
4. Emerging Trends in Medical Device Outsourcing and Contract Manufacturing
5. This Week: UBM Canon Presents an Online Event and Conference Dedicated to Emerging Trends in Medical Device Outsourcing/Contract Manufacturing
6. CMC Biologics Achieves Successful Pre-Approval European GMP Inspection by MHRA for Commercial Manufacturing
7. China Biologic Receives SFDA Manufacturing Approval Certificate for Human Coagulation Factor VIII
8. Divine Skin To Begin Manufacturing Its OTC Pain Reliever
9. ADVENTRX Announces Manufacturing Agreement With Patheon to Manufacture ANX-188 Drug Product
10. Pinnacle Biologics and INTERmedic Medical Devices announce strategic manufacturing and distribution agreement for cancer laser technology
11. Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... MARLBOROUGH, Mass. , May 2, 2016  While ... effects that osteoporosis can have on their health, only ... 1   according to the results of a new ... ). To mark the start of National Osteoporosis Month, ... women,s health, which affects nearly 56 million Americans. ...
(Date:5/2/2016)... , May 2, 2016 ... to reach USD 11.1 billion by 2024, according ... Research, Inc. Major drivers of the sonography market ... areas and government recommendations for periodic ultrasound screenings ...      (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ) ...
(Date:4/29/2016)... April 29, 2016 ReportsnReports.com ... 2016" market research report that provides an overview ... analysis at various stages, therapeutics assessment by drug ... (RoA) and molecule type, along with latest updates, ... reviews key players involved in the therapeutic development ...
Breaking Medicine Technology:
(Date:5/2/2016)... (PRWEB) , ... May 02, 2016 , ... Pregnancy Awareness ... when trying to conceive. , “If you are ready to have a ... Seibel. “My book, HealthChequesTM: Journal Babies is your Personal Conception & Pregnancy Organizer, ...
(Date:5/2/2016)... ... May 02, 2016 , ... TeleMedCo™, a ... designed to automate and improve the rapid diagnosis, triage and admission of patients ... platform, application, and mobile experience for the first time at GENBAND’s Perspectives16 conference. ...
(Date:5/2/2016)... ... May 02, 2016 , ... Consultative health ... and GM Jim Callandrillo and Duane Reed, VP of business development of AJMC ... Intelligence and Research Group (PBIRG) General Meeting from May 15-17 at the ...
(Date:5/2/2016)... ... May 02, 2016 , ... Atlantic Information Services, Inc. ... Part B Payment Model Could Transform the Pharma Landscape .” CMS recently proposed a ... its spend on provider-administered drugs while preserving care provided to beneficiaries. The webinar will ...
(Date:5/2/2016)... ... 2016 , ... For many artists, the act of blending paint is based ... a science. , Using the new, highly precise METTLER TOLEDO ML204T balance to ... and meaning to his works. What’s more, it has allowed him to recreate these ...
Breaking Medicine News(10 mins):